EPA Incorporation and Immune responses after nutritional supplementation in Cancer patients receiving RadioTherapy.
Completed
- Conditions
- Cancer patients receiving RadioTherapy
- Registration Number
- NL-OMON21909
- Lead Sponsor
- Danone Research ¨C Centre for Specialised Nutrition
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Pathologically confirmed solid tumor(s);
2. Receiving radiotherapy during the study;
Exclusion Criteria
1. Surgery and / or chemotherapy within the past 6 weeks;
2. Previous radiotherapy ( before current treatment cycles ) within the past 6 weeks;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Percentage EPA and DHA of total phospholipid fatty acids of cell membranes of white and red blood cells and plasma;<br /><br>2. Ex vivo pro-inflammatory cytokine and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-stimulated whole blood.<br>
- Secondary Outcome Measures
Name Time Method Serum cytokine and C-reactive protein (CRP) levels.